tradingkey.logo

Cosmos Health Inc

COSM

0.880USD

+0.021+2.40%
Market hours ETQuotes delayed by 15 min
23.93MMarket Cap
LossP/E TTM

Cosmos Health Inc

0.880

+0.021+2.40%
More Details of Cosmos Health Inc Company
Cosmos Health Inc. is a global healthcare company. The Company owns a portfolio of pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe and C-Sept. Through its subsidiary, Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It distributes a line of pharmaceuticals and Para pharmaceuticals, including branded generics and over the counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It is also engaged in the research and development (R&D) of patented nutraceuticals and specialized root extracts as well as in the R&D of complex generics and OTC products. It offers Cloudscreen, a multimodal platform specialized in drug repurposing, a process of uncovering new target proteins. It is also specialized in the storage and distribution of pharmaceutical and Para pharmaceutical goods.
Company Info
Ticker SymbolCOSM
Company nameCosmos Health Inc
IPO dateMay 19, 2010
CEOMr. Grigorios Siokas
Number of employees149
Security typeOrdinary Share
Fiscal year-endMay 19
Address- -
City- -
Stock exchangeNASDAQ Capital Market Consolidated
Country- -
Postal code- -
Phone- -
Website- -
Ticker SymbolCOSM
IPO dateMay 19, 2010
CEOMr. Grigorios Siokas
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Grigorios Siokas
Mr. Grigorios Siokas
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
6.16M
--
Mr. Georgios (George) Terzis
Mr. Georgios (George) Terzis
Chief Financial Officer
Chief Financial Officer
727.26K
--
Dr. Anastasios (Tasos) Aslidis
Dr. Anastasios (Tasos) Aslidis
Independent Director
Independent Director
40.00K
--
Mr. Suhel Bhutawala
Mr. Suhel Bhutawala
Independent Director
Independent Director
30.00K
--
Mr. Demetrios G. Demetriades
Mr. Demetrios G. Demetriades
Independent Director
Independent Director
20.00K
--
Dr. Manfred Ziegler
Dr. Manfred Ziegler
Independent Director
Independent Director
20.00K
--
Mr. John James Hoidas
Mr. John James Hoidas
Independent Director
Independent Director
15.00K
--
Mr. Nikos Bardakis
Mr. Nikos Bardakis
Chief Operating Officer
Chief Operating Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Grigorios Siokas
Mr. Grigorios Siokas
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
6.16M
--
Mr. Georgios (George) Terzis
Mr. Georgios (George) Terzis
Chief Financial Officer
Chief Financial Officer
727.26K
--
Dr. Anastasios (Tasos) Aslidis
Dr. Anastasios (Tasos) Aslidis
Independent Director
Independent Director
40.00K
--
Mr. Suhel Bhutawala
Mr. Suhel Bhutawala
Independent Director
Independent Director
30.00K
--
Mr. Demetrios G. Demetriades
Mr. Demetrios G. Demetriades
Independent Director
Independent Director
20.00K
--
Dr. Manfred Ziegler
Dr. Manfred Ziegler
Independent Director
Independent Director
20.00K
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
No Data
By RegionUSD
Name
Revenue
Proportion
Greece
13.32M
97.16%
UK
285.86K
2.08%
Cyprus
52.56K
0.38%
Albania
36.33K
0.26%
Bulgaria
12.18K
0.09%
Croatia (Country)
3.09K
0.02%
By Business
By Region
No Data
Shareholding Stats
Updated: Fri, Jul 25
Updated: Fri, Jul 25
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Siokas (Grigorios)
21.42%
Armistice Capital LLC
6.67%
Bovopoulos (Andreas D)
6.54%
Terzis (Georgios)
2.53%
BlackRock Institutional Trust Company, N.A.
0.93%
Other
61.91%
Shareholders
Shareholders
Proportion
Siokas (Grigorios)
21.42%
Armistice Capital LLC
6.67%
Bovopoulos (Andreas D)
6.54%
Terzis (Georgios)
2.53%
BlackRock Institutional Trust Company, N.A.
0.93%
Other
61.91%
Shareholder Types
Shareholders
Proportion
Individual Investor
31.08%
Hedge Fund
6.68%
Investment Advisor
1.77%
Investment Advisor/Hedge Fund
0.83%
Research Firm
0.02%
Other
59.60%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
47
11.61M
40.40%
+2.69M
2025Q1
46
9.62M
37.58%
+3.08M
2024Q4
46
5.58M
24.01%
-722.90K
2024Q3
47
6.02M
25.89%
+3.46M
2024Q2
49
2.80M
72.05%
-1.10M
2024Q1
49
2.81M
72.29%
-1.10M
2023Q4
49
4.12M
85.37%
+1.50M
2023Q3
46
2.84M
75.97%
+428.48K
2023Q2
43
2.78M
79.39%
+787.97K
2023Q1
33
2.36M
81.29%
+1.20M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Siokas (Grigorios)
6.16M
21.42%
-1.00
-0.00%
Jun 02, 2025
Armistice Capital LLC
1.92M
6.67%
+1.17M
+156.10%
Mar 31, 2025
Bovopoulos (Andreas D)
1.88M
6.54%
+1.88M
--
Dec 31, 2024
Terzis (Georgios)
727.26K
2.53%
--
--
Jun 02, 2025
BlackRock Institutional Trust Company, N.A.
267.80K
0.93%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
194.12K
0.68%
+685.00
+0.35%
Mar 31, 2025
The Vanguard Group, Inc.
134.83K
0.47%
--
--
Mar 31, 2025
UBS Financial Services, Inc.
61.67K
0.21%
-9.84K
-13.76%
Mar 31, 2025
Bardakis (Nikolaos)
45.00K
0.16%
--
--
Jun 02, 2025
Foundations Investment Advisors, LLC
42.50K
0.15%
+42.50K
--
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proportion0%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Dec 15, 2022
Merger
25<1
Dec 15, 2022
Merger
25<1
Dec 15, 2022
Merger
25<1
Dec 15, 2022
Merger
25<1
Date
Type
Ratio
Dec 15, 2022
Merger
25<1
Dec 15, 2022
Merger
25<1
Dec 15, 2022
Merger
25<1
Dec 15, 2022
Merger
25<1
KeyAI